Relafen 750, or Relafen, or Naproxcinod, or the medication represents a specific approach to pain relief , viewed with a biochemical pharmacy perspective. A formulation, comprising naproxcinod, seeks to modulate cyclooxygenase (COX) activity, particularly COX-2, although demonstrating limited inhibition regarding COX-1. Therefore, the potential for